Showing results for "#DCGI"
'52% Indian families have had 1 member face unknown side effects from...
The report revealed that 18 per cent families surveyed had one or more members who experienced unknown side effects thrice or more in the last 5
DCGI Approves Serum, Bharat Biotech Vaccine For Emergency Use
Vaccines of Serum Institue of India and Bharat Biotech are granted permission for restricted use in the emergency situation said DCGI in a press...
DCGI To Brief Media Today On Covid-19 Vaccine
The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
DCGI gives nod to India's first indigenous mRNA vaccine for human...
India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical...
Vaccine won't be released unless proven 'immunogenic and safe': SII on...
Addressing the concerns related to the adverse reaction reported by the volunteer in Chennai, SII said, "The Covishield vaccine is safe and...
Hetero to produce 100 mn Sputnik V doses in India
Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine...
Covaxin phase three trial to start next month
With the first two phases not throwing up any adverse effects, the phase three trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, is likely to start...
TN hopes to get DCGI nod to go ahead with trial
Even after the Serum Institute of India (SII) announced that it would pause the human trial of Covidshield, the COVID-19 vaccine developed by Oxford...
